PAPIYA KAKANI: Open Payments
NPI 1326671728 · AVENTURA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 22 payments from 12 companies in 2025. Trend: 2023 $35 · 2024 $52 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $110 |
| Boston Scientific Corporation | 2 | $100 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, WATCHMAN FLX, REPATHA, ELIQUIS, JARDIANCE, WAINUA, Optimizer, Wegovy.
Industry payments across FL — which companies pay providers there.
